February 13, 2018 / 7:21 AM / in 9 months

BRIEF-Moberg Pharma Q4 EBITDA Above Expectations At SEK 27.0 Million

Feb 13 (Reuters) - MOBERG PHARMA AB (PUBL):

* Q4 OPERATING PROFIT (EBIT) SEK 17.6 MILLION (7.1)

* Q4 EBITDA SEK 27.0 MILLION (REUTERS POLL: SEK 19.6 MILLION) Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below